je.st
news
MannKind Corporation, Danbury, Conn. Tuesday, January 26, 2016.
2016-04-05 23:31:44| Biotech - Topix.net
Shares of MannKind fell about 6 percent during trading Tuesday after the local pharmaceutical company announced it had regained the commercialization rights of its inhaled insulin, Afrezza. The commercialization of the drug had been handled in the past by Sanofi, a French pharmaceutical giant that told MannKind in January that it would no longer market the drug.
Tags: january
tuesday
corporation
conn
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||